Type 2 Diabetes Mellitus Management and Body Mass Index: Experiences with Initiating Insulin Detemir in the A sub(1)chieve Study

Introduction: This sub-analysis of the A sub(1)chieve study aimed to examine the safety and efficacy of insulin detemir (IDet) initiation over 24 weeks in relation to baseline body mass index (BMI) in people with type 2 diabetes mellitus (T2DM). Methods: A sub(1)chieve was a 24-week non-intervention...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes therapy 2014-06, Vol.5 (1), p.127-140
Main Authors: Khamseh, Mohammed E, Prusty, Vinay, Latif, Zafar, Gonzalez-Galvez, Guillermo, Dieuzeide, Guillermo, Zilov, Alexey
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: This sub-analysis of the A sub(1)chieve study aimed to examine the safety and efficacy of insulin detemir (IDet) initiation over 24 weeks in relation to baseline body mass index (BMI) in people with type 2 diabetes mellitus (T2DM). Methods: A sub(1)chieve was a 24-week non-interventional study to assess the safety and efficacy of insulin analogs in routine practice. This sub-analysis included insulin-naive patients who initiated IDet therapy based on their physicians' decision. Patients were stratified according to baseline BMI (Group I,
ISSN:1869-6953
1869-6961
DOI:10.1007/s13300-014-0054-2